Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug;20(3):e323-e329.
doi: 10.18295/squmj.2020.20.03.012. Epub 2020 Oct 5.

Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome

Hana Alzamil  1 , Khawlah Aloraini  2 , Reem AlAgeel  2 , Aya Ghanim  2 , Ruba Alsaaran  2 , Nora Alsomali  2 , Reem Albahlal  2 , Lulu Alnuaim  3
Affiliations

Disparity among Endocrinologists and Gynaecologists in the Diagnosis of Polycystic Ovarian Syndrome

Hana Alzamil et al. Sultan Qaboos Univ Med J. 2020 Aug.

Abstract

Objectives: This study aimed to compare endocrinologists' versus gynaecologists' approaches in using the Rotterdam criteria to diagnose polycystic ovarian syndrome (PCOS).

Methods: This cross-sectional study was conducted at Physiology Department, King Saud University, Riyadh, Saudi Arabia, between December 2017 and April 2018. A validated self-administered questionnaire in English was used to obtain information from endocrinologists and gynaecologists regarding their approaches to diagnosing PCOS. Each group's diagnostic use of the Rotterdam criteria, association between years of experience and clinical decision-making, clinical features leading to diagnosis and considerations in the diagnosis of biochemical parameters that define hyperandrogenism were evaluated.

Results: A total of 132 physicians were included in this study (response rate: 27%); 77 (58.3%) were endocrinologists and 55 (41.7%) were gynaecologists. Most of the respondents (79.5%) had ≤20 years of experience. A statistically significant difference was detected between the endocrinologists and gynaecologists (98.7% versus 81.8%; P = 0.001) in their consideration of hyperandrogenism in the diagnosis. The gynaecologists relied more on ovarian morphology than the endocrinologists did (76.4% versus 45.5%, P <0.0001). Physicians with more experience used ovarian ultrasonography more compared to those with less experience (P = 0.006).

Conclusion: There was disparity in the diagnostic approaches of endocrinologists, who rely more on androgen levels for diagnosis of PCOS versus gynaecologists, who more frequently use an ovarian morphology assessment. Increased years of experience increased the rate of ultrasonography use for PCOS diagnosis in both groups.

Keywords: Diagnosis; Endocrinology; Gynecology; Healthcare Disparities; Hirsutism; Hyperandrogenism; Polycystic Ovary Syndrome; Saudi Arabia.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Percentage of gynaecologists and endocrinologists using clinical features for polycystic ovarian syndrome diagnosis BMI = body mass index. *P <0.01.
Figure 2
Figure 2
Percentage of gynaecologists and endocrinologists using biochemical parameters as clinical features for polycystic ovarian syndrome diagnosis AS = androstendione; FAI = free androgen index; DHEAS = dehydroepiandrosterone sulfate; TT = total testosterone; FT = free testosterone. *P <0.05. †P <0.0001.
See this image and copyright information in PMC

References

    1. Sivayoganathan D, Maruthini D, Glanville JM, Balen AH. Full investigation of patients with polycystic ovary syndrome (PCOS) presenting to four different clinical specialties reveals significant differences and undiagnosed morbidity. Hum Fertil (Camb) 2011;14:261–5. doi: 10.3109/14647273.2011.632058. - DOI - PubMed
    1. Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: Guide to the best practices in the evaluation and treatment of polycystic ovary syndrome--Part 1. Endocr Pract. 2015;21:1291–300. doi: 10.4158/EP15748.DSC. - DOI - PubMed
    1. Lizneva D, Suturina L, Walker W, Brakta S, Gavrilova-Jordan L, Azziz R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil Steril. 2016;106:6–15. doi: 10.1016/j.fertnstert.2016.05.003. - DOI - PubMed
    1. Podfigurna-Stopa A, Luisi S, Regini C, Katulski K, Centini G, Meczekalski B, et al. Mood disorders and quality of life in polycystic ovary syndrome. Gynecol Endocrinol. 2015;31:431–4. doi: 10.3109/09513590.2015.1009437. - DOI - PubMed
    1. Gibson-Helm M, Teede H, Dunaif A, Dokras A. Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102:604–12. doi: 10.1210/jc.2016-2963. - DOI - PMC - PubMed